LexaGene Holdings, Inc., a molecular diagnostics company that develops fully automated, rapid pathogen detection systems, has successfully utilized the MiQLab™ System to detect the presence of a slow ...
LexaGene Holdings Inc., the creator of pathogen detection instrumentation, announced today that the firm recently conducted an industry meeting with the Department of Homeland Security’s Countering ...
BEVERLY, Mass., Jan. 18, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular ...
* Lexagene Holdings Inc - intends to complete a non-brokered private placement to raise up to $2.01 million by issuance of 6.7 million units * Lexagene Holdings Inc - proceeds from private placement ...
BEVERLY, Mass., Feb. 24, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), announces that it has ...